Natural supplement astaxanthin tested as new asthma aid in dirty air
NCT ID NCT07507682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether astaxanthin, a natural antioxidant supplement, can improve lung function and reduce airway inflammation in adults with mild-to-moderate asthma. Participants will take astaxanthin and a placebo in random order for 4 weeks each, with a break in between. The study also measures air pollution exposure to see how it affects asthma symptoms and treatment response.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AIRWAY HYPERRESPONSIVENESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Middlesex University
RECRUITINGLondon, Barnet, NW4 4BT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple breathing pattern ease asthma symptoms and improve sleep?
- Oral asthma drug KT-621 tested for Long-Term safety
- Handheld breath test could spot lung disease early
- Could a single nasal spray stop asthma Flare-Ups from colds?
- Dog allergy vaccine shows promise in small swedish trial
- Scientists probe the mystery of breathlessness to unlock better treatments